|
ACIU
|
AC Immune SA
|
US
|
NASDAQ
|
|
ACLX
|
Arcellx, Inc.
|
US
|
NASDAQ
|
|
AKTX
|
Akari Therapeutics Plc
|
US
|
NASDAQ
|
|
ALDX
|
Aldeyra Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ALIM
|
Alimera Sciences, Inc.
|
US
|
NASDAQ
|
|
ANVS
|
Annovis Bio, Inc.
|
US
|
NYSE
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
APLT
|
Applied Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
ARWR
|
Arrowhead Research Corporation
|
US
|
NASDAQ
|
|
ASRT
|
Assertio Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ATEC
|
Alphatec Holdings, Inc.
|
US
|
NASDAQ
|
|
AVDL
|
Avadel Pharmaceuticals plc
|
US
|
NASDAQ
|
|
AXGN
|
AxoGen, Inc.
|
US
|
NASDAQ
|
|
AXSM
|
Axsome Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AYTU
|
Aytu BioScience, Inc.
|
US
|
NASDAQ
|
|
BBIO
|
BridgeBio Pharma, Inc.
|
US
|
NASDAQ
|
|
BHC
|
Bausch Health Companies Inc.
|
US
|
NYSE
|
|
CNTX
|
Context Therapeutics Inc.
|
US
|
NASDAQ
|
|
CORT
|
Corcept Therapeutics Incorporated
|
US
|
NASDAQ
|